MEDLEY is a clinical feasibility study which aim to understand whether low-dose CT should be used instead of chest X-ray as the first-line investigation of symptoms of possible lung cancer.
At least 5 hospitals across the UK will be taking part and we aim to invite 900 people to take part in the study between February 2025 and January 2026. You cannot be referred directly into the study by your GP, or self-refer into the study. The only way to participate is if you are invited by a member of the MEDLEY team from one of the participating centres.
MEDLEY is funded by the National Institute for Health and Care Research (NIHR131475), and is Sponsored by the University of Leeds.
MEDLEY is funded by the National Institute for Health and Care Research (NIHR131475), and the views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Participating centres
There are 5 hospitals currently taking part in the MEDLEY trial.
| Centre Name |
|---|
| Leeds Teaching Hospitals |
| Manchester University Hospitals |
| Royal United Hospitals Bath |
| Hull University Teaching Hospitals |
| University Hospitals North Midlands |